Literature DB >> 27650398

High-intensity interval training prevents oxidant-mediated diaphragm muscle weakness in hypertensive mice.

T Scott Bowen1, Sophia Eisenkolb2, Juliane Drobner2, Tina Fischer2, Sarah Werner2, Axel Linke2, Norman Mangner2, Gerhard Schuler2, Volker Adams2.   

Abstract

Hypertension is a key risk factor for heart failure, with the latter characterized by diaphragm muscle weakness that is mediated in part by increased oxidative stress. In the present study, we used a deoxycorticosterone acetate (DOCA)-salt mouse model to determine whether hypertension could independently induce diaphragm dysfunction and further investigated the effects of high-intensity interval training (HIIT). Sham-treated (n = 11), DOCA-salt-treated (n = 11), and DOCA-salt+HIIT-treated (n = 15) mice were studied over 4 wk. Diaphragm contractile function, protein expression, enzyme activity, and fiber cross-sectional area and type were subsequently determined. Elevated blood pressure confirmed hypertension in DOCA-salt mice independent of HIIT (P < 0.05). Diaphragm forces were impaired by ∼15-20% in DOCA-salt vs. sham-treated mice (P < 0.05), but this effect was prevented after HIIT. Myosin heavy chain (MyHC) protein expression tended to decrease (∼30%; P = 0.06) in DOCA-salt vs. sham- and DOCA-salt+HIIT mice, whereas oxidative stress increased (P < 0.05). Enzyme activity of NADPH oxidase was higher, but superoxide dismutase was lower, with MyHC oxidation elevated by ∼50%. HIIT further prevented direct oxidant-mediated diaphragm contractile dysfunction (P < 0.05) after a 30 min exposure to H2O-2 (1 mM). Our data suggest that hypertension induces diaphragm contractile dysfunction via an oxidant-mediated mechanism that is prevented by HIIT.-Bowen, T. S., Eisenkolb, S., Drobner, J., Fischer, T., Werner, S., Linke, A., Mangner, N., Schuler, G., Adams, V. High-intensity interval training prevents oxidant-mediated diaphragm muscle weakness in hypertensive mice. © FASEB.

Entities:  

Keywords:  exercise; heart failure; skeletal muscle

Mesh:

Substances:

Year:  2016        PMID: 27650398     DOI: 10.1096/fj.201600672R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Skeletal myofiber VEGF deficiency leads to mitochondrial, structural, and contractile alterations in mouse diaphragm.

Authors:  Daniel T Cannon; Lukas Rodewohl; Volker Adams; Ellen C Breen; T Scott Bowen
Journal:  J Appl Physiol (1985)       Date:  2019-09-05

Review 2.  Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies.

Authors:  Qingyi Zhan; Wenjing Peng; Siqi Wang; Juan Gao
Journal:  J Cardiovasc Transl Res       Date:  2022-09-28       Impact factor: 3.216

3.  Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.

Authors:  T Scott Bowen; Dominic Brauer; Natale P L Rolim; Fredrik H Bækkerud; Angela Kricke; Anne-Marie Ormbostad Berre; Tina Fischer; Axel Linke; Gustavo Justo da Silva; Ulrik Wisloff; Volker Adams
Journal:  J Am Heart Assoc       Date:  2017-10-24       Impact factor: 5.501

4.  Myofibrillar function differs markedly between denervated and dexamethasone-treated rat skeletal muscles: Role of mechanical load.

Authors:  Takashi Yamada; Yuki Ashida; Daisuke Tatebayashi; Koichi Himori
Journal:  PLoS One       Date:  2019-10-09       Impact factor: 3.240

5.  Small-molecule-mediated chemical knock-down of MuRF1/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure.

Authors:  Volker Adams; T Scott Bowen; Sarah Werner; Peggy Barthel; Christina Amberger; Anne Konzer; Johannes Graumann; Peter Sehr; Joe Lewis; Jan Provaznik; Vladimir Benes; Petra Büttner; Alexander Gasch; Norman Mangner; Christian C Witt; Dittmar Labeit; Axel Linke; Siegfried Labeit
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-05-29       Impact factor: 12.910

Review 6.  Impacts of exercise interventions on different diseases and organ functions in mice.

Authors:  Shanshan Guo; Yiru Huang; Yan Zhang; He Huang; Shangyu Hong; Tiemin Liu
Journal:  J Sport Health Sci       Date:  2019-07-13       Impact factor: 7.179

Review 7.  Heart failure with preserved ejection fraction: present status and future directions.

Authors:  Somy Yoon; Gwang Hyeon Eom
Journal:  Exp Mol Med       Date:  2019-12-19       Impact factor: 8.718

Review 8.  Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.

Authors:  Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 29.983

9.  Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.

Authors:  Thomas Scott Bowen; Volker Adams; Sarah Werner; Tina Fischer; Paulien Vinke; Maria Noel Brogger; Norman Mangner; Axel Linke; Peter Sehr; Joe Lewis; Dittmar Labeit; Alexander Gasch; Siegfried Labeit
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-09-08       Impact factor: 12.910

10.  Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".

Authors:  Maria Valero-Muñoz; Warren Backman; Flora Sam
Journal:  JACC Basic Transl Sci       Date:  2017-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.